ReviewFrontiers in pain research (Lausanne, Switzerland)2026
Electromagnetic neuromodulation for chronic pain: historical context, contemporary modalities, and evidence gaps.
Review in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Electromagnetic neuromodulation is increasingly used as an adjunct or alternative to pharmacologic therapy for pain, with several approaches cleared for select indications and many others under active investigation. We review implanted neuromodulation approaches (intracranial and spinal), vagal neuromodulation, noninvasive central/cranial neuromodulation, peripheral neuromodulation, and hybrid/multimodal approaches, with a primary focus on chronic pain management and brief coverage of selected acute-use indications (e.g., primary headache disorders) where relevant. Beyond summarizing individual modalities, we highlight the recurring patterns that have shaped the evolution of pain neuromodulation. For each modality, we summarize putative mechanism of action, typical stimulation paradigms, and key strengths and limitations of the clinical evidence, emphasizing sources of heterogeneity that complicate cross-study comparison and translation. We conclude by outlining priorities for the field, including more rigorous trial design, standardized reporting of stimulation parameters and outcomes, and clearer indication-specific evidence to support clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.